Literature DB >> 21654084

Growth inhibitory, apoptotic and anti-inflammatory activities displayed by a novel modified triterpenoid, cyano enone of methyl boswellates.

Palaniyandi Ravanan1, Sanjay K Singh, Gsr Subba Rao, Paturu Kondaiah.   

Abstract

Triterpenoids are pentacyclic secondary metabolites present in many terrestrial plants. Natural triterpenoids have been reported to exhibit anti-inflammatory and anti-carcinogenic activities. Here, we show that modifications of ring A of boswellic acid (2 cyano, 3 enone) resulted in a highly active growth inhibitory, anti-inflammatory, prodifferentiative and anti-tumour triterpenoid compound called cyano enone of methyl boswellates (CEMB). This compound showed cytotoxic activity on a number of cancer cell lines with IC₅₀ ranging from 0.2 to 0.6 μM. CEMB inhibits DNA synthesis and induces apoptosis in A549 cell line at 0.25 μM and 1 μM concentrations, respectively. CEMB induces adipogenic differentiation in 3T3-L1 cells at a concentration of 0.1 μM. Finally, administration of CEMB intra-tumourally significantly inhibited the growth of C6 glioma tumour xenograft in immuno-compromised mice. Collectively, these results suggest that CEMB is a very potent anti-tumour compound.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654084     DOI: 10.1007/s12038-011-9056-7

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  35 in total

1.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Authors:  Marina Konopleva; Twee Tsao; Peter Ruvolo; Irina Stiouf; Zeev Estrov; Clinton E Leysath; Shourong Zhao; David Harris; Shirong Chang; C Ellen Jackson; Mark Munsell; Nanjoo Suh; Gordon Gribble; Tadashi Honda; W Stratford May; Michael B Sporn; Michael Andreeff
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 2.  Molecular thanatopsis: a discourse on the BCL2 family and cell death.

Authors:  E Yang; S J Korsmeyer
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

3.  Novel synthetic oleanane triterpenoids: a series of highly active inhibitors of nitric oxide production in mouse macrophages.

Authors:  T Honda; B V Rounds; L Bore; F G Favaloro; G W Gribble; N Suh; Y Wang; M B Spor
Journal:  Bioorg Med Chem Lett       Date:  1999-12-20       Impact factor: 2.823

4.  Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells.

Authors:  Marina Konopleva; Weiguo Zhang; Yue-Xi Shi; Teresa McQueen; Twee Tsao; Maen Abdelrahim; Mark F Munsell; Mary Johansen; Dihua Yu; Timothy Madden; Stephen H Safe; Mien-Chie Hung; Michael Andreeff
Journal:  Mol Cancer Ther       Date:  2006-02       Impact factor: 6.261

Review 5.  Role of nitric oxide in tumor progression: lessons from experimental tumors.

Authors:  P K Lala; A Orucevic
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

6.  The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore.

Authors:  Paul S Brookes; Kimberly Morse; Denise Ray; Andrew Tompkins; Sara M Young; Shannon Hilchey; Suhail Salim; Marina Konopleva; Michael Andreeff; Richard Phipps; Steven H Bernstein
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.

Authors:  Marc L Hyer; Ranxin Shi; Maryla Krajewska; Colin Meyer; Irina V Lebedeva; Paul B Fisher; John C Reed
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

9.  A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity.

Authors:  N Suh; Y Wang; T Honda; G W Gribble; E Dmitrovsky; W F Hickey; R A Maue; A E Place; D M Porter; M J Spinella; C R Williams; G Wu; A J Dannenberg; K C Flanders; J J Letterio; D J Mangelsdorf; C F Nathan; L Nguyen; W W Porter; R F Ren; A B Roberts; N S Roche; K Subbaramaiah; M B Sporn
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

Review 10.  Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

Authors:  Karen T Liby; Mark M Yore; Michael B Sporn
Journal:  Nat Rev Cancer       Date:  2007-04-19       Impact factor: 60.716

View more
  6 in total

Review 1.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

Review 2.  A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress.

Authors:  Namrata Chaudhari; Priti Talwar; Avinash Parimisetty; Christian Lefebvre d'Hellencourt; Palaniyandi Ravanan
Journal:  Front Cell Neurosci       Date:  2014-07-29       Impact factor: 5.505

Review 3.  Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Authors:  Ajaikumar B Kunnumakkara; Kishore Banik; Devivasha Bordoloi; Choudhary Harsha; Bethsebie L Sailo; Ganesan Padmavathi; Nand K Roy; Subash C Gupta; Bharat B Aggarwal
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

4.  In vitro Antibacterial Effect of Hydroalcoholic Extract of Lawsonia inermis, Malva sylvestris, and Boswellia serrata on Aggregatibacter actinomycetemcomitans.

Authors:  Surena Vahabi; Mojdeh Hakemi-Vala; Samaneh Gholami
Journal:  Adv Biomed Res       Date:  2019-03-20

Review 5.  An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Authors:  Nand Kishor Roy; Dey Parama; Kishore Banik; Devivasha Bordoloi; Amrita Khwairakpam Devi; Krishan Kumar Thakur; Ganesan Padmavathi; Mehdi Shakibaei; Lu Fan; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

6.  Boswellia serrata Extract as an Antibiofilm Agent against Candida spp.

Authors:  Petr Jaroš; Maria Vrublevskaya; Kristýna Lokočová; Jana Michailidu; Irena Kolouchová; Kateřina Demnerová
Journal:  Microorganisms       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.